APA (7th ed.) Citation

Fatemeh Hayati, Heshmatollah Shahbazian, Ali Ghorbani, Shahla Ahmadi Halili, Eisa Rezaei, Leila Sabetnia, & Seyed Seifollah Beladi Mousavi. (2019). Mycophenolate mofetil versus cyclophosphamide for idiopathic membranous nephropathy; a double blind and randomized clinical trial. Society of Diabetic Nephropathy Prevention.

Chicago Style (17th ed.) Citation

Fatemeh Hayati, Heshmatollah Shahbazian, Ali Ghorbani, Shahla Ahmadi Halili, Eisa Rezaei, Leila Sabetnia, and Seyed Seifollah Beladi Mousavi. Mycophenolate Mofetil Versus Cyclophosphamide for Idiopathic Membranous Nephropathy; a Double Blind and Randomized Clinical Trial. Society of Diabetic Nephropathy Prevention, 2019.

MLA (9th ed.) Citation

Fatemeh Hayati, et al. Mycophenolate Mofetil Versus Cyclophosphamide for Idiopathic Membranous Nephropathy; a Double Blind and Randomized Clinical Trial. Society of Diabetic Nephropathy Prevention, 2019.